Amarin Corp Plc (AMRN)

[ziploc_1]

KM entered a dire situation a year ago and has performed well...
1. He introduced Vaskepa to the German market.
2. He arranged for government payments for Vaskepa in Sweden at a fair price...and got approval in the U.K.
3. He has made good progress on approval in France and other EU nations.
4. He has taken necessary steps to cut overhead.
5. He has also taken necessary steps to stem the tide of generic infringement by offering rebates to insurance companies in the U.S.

Having recently assumed the job of CEO, he was no position to correct the errors of commission and omission that the entrenched BOD had made over a period of years.

He could be faulted for continuing the GIA policy, but it was in force when he was appointed as CEO...and he had little authority to turn it around in the less than a year that he was on the job.